Search - tctmd.com

Displaying 501 - 520 of 586

Sort: Relevancy | Date

Presentation

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel in Stable CAD Patients

Presenter: Matthew J. Price

June 13, 2012

News Daily News

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Caitlin E. Cox

June 07, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

Yael L. Maxwell

June 01, 2012

News Daily News

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

Yael L. Maxwell

June 01, 2012

News Daily News

TRITON-TIMI 38 Analysis: In CABG Patients, Mortality Benefit with Prasugrel Despite Higher Bleeding Risk

L.A. McKeown

May 29, 2012

News Daily News

Análisis TRITON-TIMI 38: En Pacientes sometidos a CABG, se observa un Beneficio en la Mortalidad con el Prasgurel aunque también un Mayor Riesgo Hemorrágico

L.A. McKeown

May 29, 2012

Presentation

Mortality Benefit with Prasugrel in the TRITON-TIMI 38 CABG Cohort

Presenter: 195949|Peter Smith

May 25, 2012

News Daily News

Se Publica el GIFT: Confirmado el Papel del CYP2C19 en la Variabilidad de la Respuesta al Clopidogrel

L.A. McKeown

May 23, 2012

News Daily News

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

L.A. McKeown

May 23, 2012

News Daily News

Una Dosis Alta de Recarga de Prasugrel es Mejor a la hora de Suprimir la Reactividad Plaquetaria que Antecede a una PCI

Jason Kahn

May 01, 2012

News Daily News

High Prasugrel Reloading Dose Best for Suppressing Platelet Reactivity Prior to PCI

Jason Kahn

May 01, 2012

Presentation

Pharmacodynamic Effects of Prasugrel Dosing Regimens in Pts on Maintenance Prasugrel Therapy

Presenter: A. Tello-Montoliu

April 30, 2012

News Daily News

TRIGGER-PCI Published: Halted Trial Questions Platelet Testing in Stable Patients

April 19, 2012

News Daily News

Se Publica el TRIGGER-PCI: La Interrupción del Ensayo Cuestiona la Prueba Plaquetaria en Pacientes Estables

April 19, 2012

Presentation

A Randomized Trial of Prasugrel vs. Clopidogrel in Patients with High Platelet Reactivity on Clopidogrel After Elective PCI with DES

Presenter: Dietmar Trenk

April 18, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Daily News

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

Caitlin E. Cox

March 30, 2012

News Daily News

El Genotipado Rápido a Pie de Cama podría Determinar la Estrategia Antiplaquetaria tras una PCI

Caitlin E. Cox

March 30, 2012

News Industry News

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

March 26, 2012

Advertisement

Recovery of Platelet Function After Discontinuation of Prasugrel or Clopidogrel in Stable CAD Patients

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Subestudio PLATO: Los Pacientes con SCA y Antecedentes de ACV no están en Desventaja con el Ticagrelor

PLATO Substudy: ACS Patients with Prior Stroke at No Disadvantage with Ticagrelor

TRITON-TIMI 38 Analysis: In CABG Patients, Mortality Benefit with Prasugrel Despite Higher Bleeding Risk

Análisis TRITON-TIMI 38: En Pacientes sometidos a CABG, se observa un Beneficio en la Mortalidad con el Prasgurel aunque también un Mayor Riesgo Hemorrágico

Mortality Benefit with Prasugrel in the TRITON-TIMI 38 CABG Cohort

Se Publica el GIFT: Confirmado el Papel del CYP2C19 en la Variabilidad de la Respuesta al Clopidogrel

GIFT Published: Role of CYP2C19 in Clopidogrel Response Variability Confirmed

Una Dosis Alta de Recarga de Prasugrel es Mejor a la hora de Suprimir la Reactividad Plaquetaria que Antecede a una PCI

High Prasugrel Reloading Dose Best for Suppressing Platelet Reactivity Prior to PCI

Pharmacodynamic Effects of Prasugrel Dosing Regimens in Pts on Maintenance Prasugrel Therapy

TRIGGER-PCI Published: Halted Trial Questions Platelet Testing in Stable Patients

Se Publica el TRIGGER-PCI: La Interrupción del Ensayo Cuestiona la Prueba Plaquetaria en Pacientes Estables

A Randomized Trial of Prasugrel vs. Clopidogrel in Patients with High Platelet Reactivity on Clopidogrel After Elective PCI with DES

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Rapid Bedside Genotyping May Help Guide Antiplatelet Strategy After PCI

El Genotipado Rápido a Pie de Cama podría Determinar la Estrategia Antiplaquetaria tras una PCI

Boston Scientific Supports New Clinical Trial to Evaluate Platinum Chromium Coronary Stents in Treating Heart Attack Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content